Nutrition Board of the National Academy of Sciences (NRC 1989) . Klevay and Medeiros (1996) and Klevay (1998) reported that 61% of the diets in Canada, Belgium, the U.K. and the U.S. provide Ͻ1.5 mg Cu/d, and almost one third provide Ͻ1 mg Cu/d. Low Cu intakes have been implicated in ischemic heart disease and osteoporosis; control of blood pressure, cholesterol and glucose metabolism also require adequate intakes of Cu (Klevay, 1998) .
Unfortunately, reliable noninvasive procedures to assess Cu status in humans are not available. For this reason, there is no RDA for Cu, only a suggested adequate intake level of 1.5-3.0 mg/d for adults (NRC 1989) . It is well established that high zinc, ascorbic acid and cysteine intakes reduce Cu absorption (Aoyagi and Baker 1994 , Baker and Czarnecki-Maulden 1987 , Di Silvestro and Harris 1981 , Hill and Starcher 1965 , Magee and Matrone 1962 , Milne and Omaye 1980 , Murthy et al. 1974 , Van Campen and Gross, 1968 , Van Campen and Scaife 1967 , Van Den Berg and Beynen 1992 . A scenario could be suggested in which a segment of the population was restricting energy intake and also consuming megadoses of ascorbic acid and zinc together with a vitamin-mineral supplement contain- Cu) would be good choices. Clearly, chemical, physical and organoleptic properties of Cu salts must be considered. The resulting pill or tablet may be larger, but at least it will furnish Cu in a form that can be utilized.
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